We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Nasal Cannula System Alleviates Respiratory Distress

By HospiMedica International staff writers
Posted on 22 Oct 2018
An updated non-invasive ventilation system augments breathing in patients suffering from respiratory distress in the hospital setting.

The Vapotherm (Exeter, NC, USA) Precision Flow Plus Hi-VNI system is designed to flush out carbon dioxide (CO2) laden and oxygen (O2) depleted exhaled air from the respiratory dead space in the upper airway of spontaneously breathing patients, replacing it with optimally humidified O2 rich breathing gas delivered through a high flow nasal cannula (HFNC). More...
A small-bore cannula and circuit facilitate more efficient dead space washout, with a resulting improvement in ventilation efficiency that reduces the work of breathing in such patients, relieving symptoms.

The Precision Flow Plus optimizes Hi-VNI technology by controlling O2 flow (up to 40 L/minute), O2 concentration, and temperature with a single button, integration with nurse call systems (including alarms), connectivity with the patient’s electronic medical record (EMR) to improve workflow and simplify charting, and a new approach to standby modes that enhances usability. Since no mask is present, patients are able to eat, drink, speak, participate in their care, and avoid mask-related risks of claustrophobia, aspiration, and pressure ulcers.

“Hi-VNI Technology has become an important tool for treating patients in undifferentiated respiratory distress,” said Joe Army, CEO of Vapotherm. “Our customers like having one simple tool to treat hypercapnia, hypoxia, and dyspnea. They also appreciate the convenience of a tool safe enough to be started high for maximum results, and then de-escalated as symptoms subside.”

“Many patients with respiratory distress have difficulty with the full face mask. They can become claustrophobic, making the respiratory failure worse,” said Aaron Boyd, MBA, MD, chief medical officer of Norman Regional Health System (OK, USA). “Vapotherm's technology helps our clinicians safely and efficiently treats these patients much more comfortably and less invasively.”

A recent clinical study of 204 patients at five U.S. emergency departments showed that Vapotherm Hi-VNI Technology is non-inferior to current standard non-invasive positive pressure ventilation (NiPPV) in preventing mechanical ventilation, regardless of the underlying cause of the respiratory distress. By mitigating the risk of mechanical ventilation, the risk of infections, ventilator dependence, and mortality, as well as incurring costs to the hospital, are reduced.

Related Links:
Vapotherm


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Patient Monitoring System
AlarmSense
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Brain PET imaging could help identify Alzheimer’s patients most likely to benefit from available therapies (Image Credit: iStock)

Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy

Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.